Trial Profile
A comparative, randomised, masked, controlled trial to study structural and functional assessment of macula in patients with high-risk proliferative diabetic retinopathy.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 27 Nov 2015
Price :
$35
*
At a glance
- Drugs Bevacizumab (Primary)
- Indications Diabetic retinopathy
- Focus Therapeutic Use
- 27 Nov 2015 New trial record